FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
November 04, 2024 06:00 ET
|
R3 Vascular
MOUNTAIN VIEW, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating...
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
May 09, 2024 12:00 ET
|
R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
Global Airway Stent Market Size To Worth USD 14.5 Billion By 2030 | CAGR of 7.7%
March 28, 2023 13:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , March 28, 2023 (GLOBE NEWSWIRE) -- The Global Airway Stent Market Size to grow from USD 8.8 Billion in 2021 to USD 14.5 Billion by 2030, at a Compound Annual Growth Rate...
Dr. Scott & Jill Kelley Introduce Life-Saving Medical Technology to Curb Postoperative Complications and Deaths
December 20, 2022 17:00 ET
|
Dr. Scott Kelley
TAMPA, FLORIDA, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Dr. Scott & Jill Kelley Introduce Life-Saving Medical Technology to Curb Postoperative Complications and Deaths Entrepreneurs Dr. Scott and...
Vascular Graft Market Size is Expected to Reach $8.13 Billion by 2030: Allied Market Research
June 13, 2022 07:25 ET
|
Allied Market Research
Portland, OR, June 13, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Vascular Graft Market generated $4.99 billion in 2020, and is projected to...
Gel Stent Market Global Sales Are Expected To Reach US$ 4.90 Billion by 2030, as stated by insightSLICE
March 01, 2021 09:51 ET
|
insightSLICE
PUNE, India, March 01, 2021 (GLOBE NEWSWIRE) -- The Global Gel Stent Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research...
AngioSoma Focusing on Development of Coating for Metal Stents
May 27, 2020 10:42 ET
|
AngioSoma, Inc.
Houston, TX, May 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company is focusing on development and...
Amaranth Presented MAGNITUDE (98 micron) Nine-Month Follow-up Clinical Results and Introduced DEFIANCE (85 micron) BRS Development Plan at TCT
September 24, 2018 07:59 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , Sept. 24, 2018 (GLOBE NEWSWIRE) -- Amaranth Medical, a medical device company developing next-generation bioresorbable scaffolds, provided an update on the company’s...
InspireMD’s CGuard EPS Featured at the SBHCI Congress in Brazil
June 20, 2018 07:20 ET
|
InspireMD, Inc.
Tel Aviv, Israel, June 20, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today...
InspireMD’s CGuard EPS Prominently Featured at the 10th International Congress of the Polish Society for Vascular Surgery
June 18, 2018 09:42 ET
|
InspireMD, Inc.
Study results presented from 46 patients treated over two years with zero complicationsPresident of the Polish Society for Vascular Surgery presented clinical cases illustrating the advantages of...